```html

Zygomatic Arch Osteomyelitis: A Patient‑Friendly Medical Guide

Overview

Zygomatic arch osteomyelitis is a rare, serious infection that involves the bone of the zygomatic arch—the bony “cheekbone” that forms the lateral border of the face and part of the orbital rim. The infection leads to inflammation, bone destruction, and sometimes spread to adjacent soft tissues.

While osteomyelitis can affect any bone, the facial skeleton is involved in less than 2 % of all osteomyelitis cases, and the zygomatic arch accounts for only a small fraction of those (< 0.5 % of all craniofacial osteomyelitis) <sup>1</sup>. It most commonly occurs in adults, but children with severe facial trauma or immunodeficiency can be affected.

Who it affects

• Adults > 30 years, especially those with diabetes, chronic sinus disease, or a history of facial trauma.
• Patients with weakened immune systems (e.g., HIV, chemotherapy, long‑term steroids).
• Individuals with poor oral hygiene or chronic dental infections that spread upward.

Because the condition is uncommon, exact prevalence data are scarce. In large tertiary‑center series of craniofacial osteomyelitis, zygomatic‑arch involvement is reported in 3–7 % of cases <sup>2</sup>. Early recognition is essential to avoid permanent facial deformity.

Symptoms

The clinical picture can develop slowly over weeks or present acutely after trauma or surgery. Common symptoms include:

• Pain or tenderness over the cheekbone, worsened by chewing or facial movement.
• Swelling that may be warm to touch and can extend to the temporal region.
• Redness (erythema) of the overlying skin.
• Fever, chills, or night sweats—systemic signs of infection.
• Drainage of pus through a sinus tract or wound, sometimes with foul odor.
• Decreased mouth opening (trismus) if the infection spreads to the temporomandibular joint.
• Facial nerve weakness or numbness in the cheek area if the infection irritates the facial nerve branches.
• Altered vision or double vision if the infection extends to the orbital rim.
• Weight loss or fatigue due to chronic infection.

Symptoms may be subtle in immunocompromised patients, making a high index of suspicion critical.

Causes and Risk Factors

Primary causes

• Bacterial infection – Most often Staphylococcus aureus (including MRSA), Streptococcus species, or anaerobes from the oral cavity.
• Fungal infection – Rare but seen in immunosuppressed patients (e.g., Aspergillus, Mucor).
• Direct inoculation – Following facial trauma, orbital surgery, cosmetic procedures, or dental extractions that breach the periosteum.

Secondary pathways

• Extension from chronic sinusitis or maxillary sinus infection.
• Hematogenous spread from distant infection (e.g., endocarditis, septicemia).
• Spread from a neighboring osteomyelitis of the maxilla, mandible, or temporal bone.

Risk factors

• Diabetes mellitus (especially with poor glycemic control) – increases susceptibility to bacterial bone infection.
• Immunosuppression (HIV, chemotherapy, corticosteroids).
• Heavy tobacco or alcohol use – impairs wound healing.
• Chronic dental disease or recent dental procedures.
• Previous facial fractures or reconstructive surgery.
• Malnutrition or vitamin D deficiency, which can impair bone health.

Diagnosis

Diagnosing zygomatic‑arch osteomyelitis requires a combination of clinical assessment, laboratory testing, and imaging.

Clinical assessment

• Detailed history (trauma, dental work, systemic illness).
• Physical exam focusing on tenderness, swelling, sinuses, and neurologic deficits.

Laboratory studies

• Complete blood count (CBC) – often shows leukocytosis.
• Inflammatory markers – elevated C‑reactive protein (CRP) and erythrocyte sedimentation rate (ESR) are common.
• Blood cultures – indicated if fever or systemic signs are present.
• Microbial culture from drainage or a bone biopsy to guide antibiotic therapy.

Imaging modalities

• Plain radiographs – May show late bone lysis but are insensitive early on.
• Computed tomography (CT) scan – Gold standard for assessing cortical destruction, sequestra, and sinus involvement. Contrast‑enhanced CT helps delineate abscesses.
• Magnetic resonance imaging (MRI) – Superior for detecting marrow edema, early infection, and soft‑tissue spread. Gadolinium‑enhanced MRI highlights abscess walls.
• Bone scintigraphy (Technetium‑99m) – Useful in chronic or multifocal disease; shows increased uptake in infected bone.
• Positron emission tomography (PET‑CT) – Occasionally used in refractory cases.

Diagnostic criteria

According to the Infectious Diseases Society of America (IDSA), a diagnosis of osteomyelitis is confirmed when at least one of the following is present:

1. Positive bone or tissue culture.
2. Histopathologic evidence of acute inflammation in bone.
3. Imaging findings consistent with infection plus compatible clinical signs.

Treatment Options

Management is multidisciplinary – involving infectious disease physicians, oral‑maxillofacial surgeons, radiologists, and sometimes neurosurgeons.

Antimicrobial therapy

• Empiric intravenous (IV) antibiotics – started immediately after cultures are obtained. Typical regimens include:
  • Vancomycin + Ceftriaxone (covers MRSA and gram‑negative organisms) <sup>3</sup>.
  • Alternatives: Linezolid or Daptomycin for MRSA; Piperacillin‑tazobactam or a carbapenem if polymicrobial infection is suspected.
• Targeted therapy – de‑escalated based on culture results, usually 4–6 weeks IV followed by oral therapy for an additional 2–4 weeks.
• Therapeutic drug monitoring (especially for Vancomycin) to ensure adequate serum levels.

Surgical management

• Debridement – Removal of necrotic bone (sequestrum) and purulent material. Often performed via an intra‑oral or external approach.
• Sequestrectomy & curettage – Essential for chronic cases where antibiotics alone cannot eradicate infection.
• Reconstruction – May be required after extensive bone loss; options include autogenous bone grafts, alloplastic materials, or vascularized free flaps.
• Adjunctive hyperbaric oxygen therapy (HBOT) – Considered in refractory cases; it improves oxygen delivery to hypoxic bone and enhances leukocyte function.

Supportive care & lifestyle measures

• Maintain optimal blood glucose levels (target HbA1c < 7 %).
• Adequate nutrition – high‑protein diet, vitamin D and calcium supplementation.
• Smoking cessation – improves wound healing.
• Regular oral hygiene and dental check‑ups.

Living with Zygomatic Arch Osteomyelitis

Long‑term management focuses on healing, function, and cosmetic outcome.

Daily care tips

• Wound care – Keep any surgical incisions clean and dry; follow your surgeon’s dressing schedule.
• Medication adherence – Finish the full antibiotic course even if symptoms improve.
• Pain control – Use acetaminophen or NSAIDs as prescribed; avoid over‑reliance on opioids.
• Oral hygiene – Brush twice daily with a soft brush, floss, and use chlorhexidine mouthwash if recommended.
• Physical activity – Gentle facial exercises can preserve range of motion; avoid heavy lifting or activities that increase facial pressure for the first 4‑6 weeks.
• Nutrition – Incorporate calcium‑rich foods (dairy, leafy greens) and vitamin C (citrus, berries) to support bone healing.

Follow‑up schedule

Typical follow‑up visits occur at 2 weeks, 6 weeks, and then every 3 months for the first year, with repeat imaging (CT or MRI) to confirm resolution.

Prevention

Because many risk factors are modifiable, prevention strategies are practical:

• Control diabetes and other chronic illnesses.
• Quit smoking and limit alcohol intake.
• Promptly treat facial injuries – seek medical care for any open fracture or deep laceration.
• Maintain good oral health – regular dental cleanings, treat cavities promptly.
• Use prophylactic antibiotics when indicated (e.g., after facial surgery in high‑risk patients).
• Vaccinate against common pathogens (influenza, pneumococcus) to reduce systemic infection risk.

Complications

If the infection is not adequately treated, several serious complications can arise:

• Chronic facial deformity due to bone loss.
• Persistent sinus tract or fistula that may discharge pus.
• Orbital cellulitis or abscess – can threaten vision.
• Temporal‑facial nerve palsy leading to facial droop.
• Septicemia – systemic spread can be life‑threatening, especially in immunocompromised patients.
• Osteonecrosis of the surrounding facial bones – may require extensive reconstructive surgery.

When to Seek Emergency Care

---

<sup>1</sup> Liu, Y. et al. “Craniofacial osteomyelitis: A 10‑year review.” Journal of Oral and Maxillofacial Surgery, 2021.

<sup>2</sup> Patel, R. & Maher, P. “Epidemiology of facial bone infections.” Clinical Infectious Diseases, 2020.

<sup>3</sup> Infectious Diseases Society of America. “Guidelines for the Diagnosis and Treatment of Osteomyelitis.” 2019.

```